Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: β-Cell and islet endothelial cell destruction occurs during the progression of type 1 diabetes, but, paradoxically, β-cell proliferation is increased during this period. Altered glucose tolerance may affect β-cell mass and its association with endothelial cells. Our objective was to study the effects of glucose and inflammation on islet vascularity and on β function, mass, and insulin in immunologically tolerant anti-CD3 monoclonal antibody (mAb)-treated and prediabetic NOD mice. RESEARCH DESIGN AND METHODS: The effects of phloridzin or glucose injections on β-cells and endothelial cells were tested in prediabetic and previously diabetic NOD mice treated with anti-CD3 mAbs. Glucose tolerance, immunofluorescence staining, and examination of islet cultures ex vivo were evaluated. RESULTS: Islet endothelial cell density decreased in NOD mice and failed to recover after anti-CD3 mAb treatment despite baseline euglycemia. Glucose treatment of anti-CD3 mAb–treated mice showed increased islet vascular density and increased insulin content, which was associated with improved glucose tolerance. The increase in the vascular area was dependent on islet inflammation. Increased islet endothelial cell density was associated with increased production of vascular endothelial growth factor (VEGF) by islets from NOD mice. This response was recapitulated ex vivo by the transfer of supernatants from NOD islets cultured in high-glucose levels. CONCLUSIONS: Our results demonstrate a novel role for glucose and inflammation in the control of islet vasculature and insulin content of β-cells in prediabetic and anti-CD3–treated NOD mice. VEGF production by the islets is affected by glucose levels and is imparted by soluble factors released by inflamed islets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherry, N. A., Chen, W., Kushner, J. A., Glandt, M., Tang, Q., Tsai, S., Santamaria, P., Bluestone, J. A., Brillantes, A.-M. B., & Herold, K. C. (2007) · Endocrinology · doi:10.1210/en.2007-0358 · Cited by 169 · cited 1×
“Based on our previous studies (27), it is likely that the improved islet vasculature increases the insulin content of recovered degranulated b-cells, which accounts for the majority of b-cell mass recovery after treatment with anti-CD3 (2).”
Self-citation
Cited by
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Sims, E. K., Bundy, B. N., Stier, K., Serti, E., Lim, N., Long, S. A., Geyer, S. M., Moran, A., Greenbaum, C. J., Evans-Molina, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8980 · Cited by 377
“These clinical outcomes are similar to the effects of anti-CD3 monoclonal antibody in the nonobese diabetic model of T1D before the onset of diabetes, in which insulin granularity was improved but beta cell mass did not recover to normal amounts (48, 49).”
ResultSelf-citationPathogenesis of diabetic complications: Exploring hypoxic niche formation and HIF-1α activation
Bi, J., Zhou, W., & Tang, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116202 · Cited by 19
Elizondo, D. M., Brandy, N. Z. D., da Silva, R. L. L., de Moura, T. R., Ali, J., Yang, D., & Lipscomb, M. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-60947-x · Cited by 16
Metadata
- Authors
- Akirav, E. M., Baquero, M.-T., Opare-Addo, L. W., Akirav, M., Galvan, E., Kushner, J. A., Rimm, D. L., & Herold, K. C.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-02-21
- Volume
- 60
- Issue
- 3
- Pages
- 876-883
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2144858797
- Cited by
- 44
- References
- 1
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice. https://app.cochat.ai/papers/10.2337/db10-0793
- The paper
- Akirav, E. M., Baquero, M.-T., Opare-Addo, L. W., Akirav, M., Galvan, E., Kushner, J. A., Rimm, D. L., & Herold, K. C. (2011). Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice. Diabetes. https://doi.org/10.2337/db10-0793
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.